WHAT MAKES REVANESSE® VERSA™ UNIQUE?
In one of Revanesses clinical trials, 50% more patients treated with a comparative product experienced swelling, than patients who were treated with Revanesse® Versa™. 1
You may find that Revanesse® Versa™ will help in the improvement of your nasolabial folds (laugh lines) for up to 12 months with optimal correction. 2
DESIGNED FOR SAFETY
The Revanesse® Versa™ formula is well-studied, with over 300 patients of multiple skin types, treated in three clinical trials, with no serious adverse events reported.
A Revanesse® Versa™ treatment is minimally invasive and provides immediate results. Take control of the signs of aging and ask your healthcare provider if Revanesse® Versa™ is right for you.
1 Injection site swelling (47.2% [77/163] with Revanesse® Versa™, 71.1% [116/163] with Comparator)
2 Multicenter Study to Evaluate the Safety and Efficacy of Revanesse Ultra Retreatment 78.1% of subjects reported being improved, much improved, or very much improved at 52 weeks according to their pGAI scores.
THE NEW 1.2ML SYRINGE
A LITTLE MORE GOES A LONG WAY
Revanesse® Versa™ is the only hyaluronic acid (HA) dermal filler in the US available in a 1.2mL syringe size.
Whether you require more product to be brought to full correction or are seeking a more cost-effective treatment option; 20% more product in our syringe is another example of the Revanesse® difference and our commitment to providing pathways for patients to achieve the best possible results.